Skip to main content
NCD 70.2.1 · version 1

NCD 70.2.1: Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy)

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 70.2.1

Benefit category
Physicians' Services
Effective date
07/01/2002
Implemented 07/01/2002
Transmittal
Transmittal 153
Versions published
1
Manual section
70
Evaluation and Management of Patients - Office/hospital/home, NCD Manual (Pub. 100-03) chapter 1 part 1

TL;DR

NCD 70.2.1 sets Medicare's national policy for services provided for the diagnosis and treatment of diabetic sensory neuropathy with loss of protective sensation (aka diabetic peripheral neuropathy) under the benefit category "Physicians' Services", effective 07/01/2002 and implemented 07/01/2002. Diabetic sensory neuropathy with LOPS is a localized illness of the feet and falls within the regulation's exception to the general exclusionary rule (see 42 CFR §411.15(l)(1)(i)). Foot exams for people with diabetic sensory neuropathy with LOPS are… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

Presently, peripheral neuropathy, or diabetic sensory neuropathy, is the most common factor leading to amputation in people with diabetes. In diabetes, sensory neuropathy is an anatomically diffuse process primarily affecting sensory and autonomic fibers; however, distal motor findings may be present in advanced cases. Long nerves are affected first, with symptoms typically beginning insidiously in the toes and then advancing proximally. This leads to loss of protective sensation (LOPS), whereby a person is unable to feel minor trauma from mechanical, thermal, or chemical sources. When foot lesions are present, the reduction in autonomic nerve functions may also inhibit wound healing.

Indications and limitations of coverage

Diabetic sensory neuropathy with LOPS is a localized illness of the feet and falls within the regulation's exception to the general exclusionary rule (see 42 CFR §411.15(l)(1)(i)). Foot exams for people with diabetic sensory neuropathy with LOPS are reasonable and necessary to allow for early intervention in serious complications that typically afflict diabetics with the disease.

Effective for services furnished on or after July 1, 2002, Medicare covers, as a physician service, an evaluation (examination and treatment) of the feet no more often than every six months for individuals with a documented diagnosis of diabetic sensory neuropathy and LOPS, as long as the beneficiary has not seen a foot care specialist for some other reason in the interim. LOPS shall be diagnosed through sensory testing with the 5.07 monofilament using established guidelines, such as those developed by the National Institute of Diabetes and Digestive and Kidney Diseases guidelines. Five sites should be tested on the plantar surface of each foot, according to the National Institute of Diabetes and Digestive and Kidney Diseases guidelines. The areas must be tested randomly since the loss of protective sensation may be patchy in distribution, and the patient may get clues if the test is done rhythmically. Heavily callused areas should be avoided. As suggested by the American Podiatric Medicine Association, an absence of sensation at two or more sites out of 5 tested on either foot when tested with the 5.07 Semmes-Weinstein monofilament must be present and documented to diagnose peripheral neuropathy with loss of protective sensation.

The examination includes:

• A patient history, and

• A physical examination that must consist of at least the following elements:

• Visual inspection of forefoot and hindfoot (including toe web spaces);

• Evaluation of protective sensation;

• Evaluation of foot structure and biomechanics;

• Evaluation of vascular status and skin integrity;

• Evaluation of the need for special footwear; and

• Patient education.

A. Treatment includes, but is not limited to:

• Local care of superficial wounds;

• Debridement of corns and calluses; and

• Trimming and debridement of nails.

Text reproduced from the CMS Medicare Coverage Database record for NCD 70.2.1 version 1. View the original on cms.gov.

Local policies that build on this NCD

7 active Local Coverage Determinations cite NCD 70.2.1 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 70.2.1

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 3 current articles in the Medicare Coverage Database name NCD 70.2.1, 3 of them with a covered ICD-10-CM list, from 3 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

A56232: Billing and Coding: Foot Care

Billing and Coding, effective 2025-10-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

795 covered ICD-10-CM codes in 3 groups; 7 procedure codes: 11055, 11056, 11057, 11719, 11720, 11721, G0127. Check a diagnosis for 11055.

First covered codes: A30.0 Indeterminate leprosy; A30.1 Tuberculoid leprosy; A30.2 Borderline tuberculoid leprosy; A30.3 Borderline leprosy; A30.4 Borderline lepromatous leprosy; A30.5 Lepromatous leprosy; …

A57193: Billing and Coding: Routine Foot Care and Debridement of Nails

Billing and Coding, effective 2026-08-06 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

641 covered ICD-10-CM codes in 5 groups; 7 procedure codes: 11055, 11056, 11057, 11719, 11720, 11721, G0127. Local policy: L34246 Routine Foot Care and Debridement of Nails. Check a diagnosis for 11055.

First covered codes: A30.0 Indeterminate leprosy; A30.1 Tuberculoid leprosy; A30.2 Borderline tuberculoid leprosy; A30.3 Borderline leprosy; A30.4 Borderline lepromatous leprosy; A30.5 Lepromatous leprosy; …

A57759: Billing and Coding: Routine Foot Care and Debridement of Nails

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

244 covered ICD-10-CM codes in 4 groups; 7 procedure codes: 11055, 11056, 11057, 11719, 11720, 11721, G0127. Local policy: L33636 Routine Foot Care and Debridement of Nails. Check a diagnosis for 11055.

First covered codes: A30.0 Indeterminate leprosy; A30.1 Tuberculoid leprosy; A30.2 Borderline tuberculoid leprosy; A30.3 Borderline leprosy; A30.4 Borderline lepromatous leprosy; A30.5 Lepromatous leprosy; …

Coverage analysis history

CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links one analysis to NCD 70.2.1, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.

  1. CAG-00059N Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS) (New, Closed)

Revision history

05/2014 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 10/06/2014 Effective date: 10/1/2015. ( TN 1388 ) ( TN 1388 ) (CR 8691)

09/2012 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 01/07/2013 Effective date: 10/1/2015. ( TN 1122 ) ( TN 1122 ) (CR 7818)

04/2002 - Provided coverage as a physician service under section 1861(s)(1) of the Act. Effective and implementation dates 07/01/2002. ( TN 153 ) (CR 2060)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 70.2.1

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 70.2.1

What does NCD 70.2.1 cover?

Diabetic sensory neuropathy with LOPS is a localized illness of the feet and falls within the regulation's exception to the general exclusionary rule (see 42 CFR §411.15(l)(1)(i)). Foot exams for people with diabetic sensory neuropathy with LOPS are reasonable and necessary to allow for early intervention in serious complications that typically afflict diabetics with the disease. The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 70.2.1 take effect?

The current version (1) is effective 07/01/2002, implemented 07/01/2002, published in transmittal 153. This is the only published version.

Does a Local Coverage Determination override NCD 70.2.1?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.